Your browser doesn't support javascript.
loading
Pharmacodynamic Therapeutic Drug Monitoring for Cancer: Challenges, Advances, and Future Opportunities.
Veal, Gareth J; Amankwatia, Edward B; Paludetto, Marie-Noëlle; Möcklinghoff, Till; Thomson, Fiona; André, Nicolas; Ciccolini, Joseph; Chatelut, Etienne.
Afiliação
  • Veal GJ; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Amankwatia EB; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Paludetto MN; Institut Claudius-Regaud and Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France.
  • Möcklinghoff T; Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Thomson F; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom.
  • André N; Pediatric Hematology and Oncology Unit, La Timone University Hospital of Marseille.
  • Ciccolini J; SMARTc Unit, Center for Research on Cancer of Marseille, UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université, Marseille, France.
  • Chatelut E; Institut Claudius-Regaud and Cancer Research Center of Toulouse, Inserm U1037, Université Paul Sabatier, Toulouse, France.
Ther Drug Monit ; 41(2): 142-159, 2019 04.
Article em En | MEDLINE | ID: mdl-30883508

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Farmacocinética / Biomarcadores / Monitoramento de Medicamentos / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Ther Drug Monit Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Farmacocinética / Biomarcadores / Monitoramento de Medicamentos / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Revista: Ther Drug Monit Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido